Developer docs
API playgroundTry for free, no card

Search company profiles

Galen Growth

Full company profile

uuid0005mpa

Namestring
Galen Growth
Legal namestring
Galen Growth Asia Pte. Ltd.
Websiteurl
galengrowth.com
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Galen Growth is a privately held digital health intelligence company that builds and commercializes HealthTech Alpha, an AI-native SaaS platform aggregating and validating data on more than 12,000 digital health ventures and 2+ billion data points across funding, partnerships, clinical evidence, and regulatory signals. The platform applies a proprietary Digital Health Taxonomy, ontology framework, and Alpha Score™ metric to deliver point-in-time, governance-friendly intelligence used for benchmarking markets, evaluating ventures, and identifying partnership and M&A opportunities. Around the core platform, the company sells tiered Pro and Enterprise subscriptions, premium research reports and briefings (114+ in a public library), and a higher-margin Advisory service that applies expert judgment for ecosystem strategy, competitive benchmarking, portfolio evaluation, and due diligence.

The company serves enterprise clients across biopharma (GSK, Merck GHI), MedTech (Philips, Medtronic, GE Healthcare), insurance and reinsurance (Swiss Re, Prudential, Munich Re, Mercer Marsh Benefits, FWD, Bupa), health systems, and institutional investors (Munich Re Ventures, B Capital Group). GTM combines enterprise field sales with a product-led self-service model on the platform and channel partnerships for regional distribution — most recently an exclusive India arrangement with All Health Tech announced in December 2025. Pricing is quote-based and not publicly disclosed, reflecting a high-touch enterprise sales motion.

Galen Growth is incorporated in Singapore as Galen Growth Asia Pte. Ltd., with regional headquarters in Basel (Europe, opened 2020) and Boston (North America). The firm reports 1-10 employees, was founded in 2016, and has no disclosed institutional funding beyond a $50,000 seed round in November 2015, indicating a capital-efficient, founder-led operating model.

Short descriptiontext

Galen Growth operates HealthTech Alpha, an AI-native SaaS platform providing decision-grade intelligence on 12,000+ digital health ventures, serving enterprise clients in biopharma, MedTech, insurance, health systems, and institutional investing across APAC, Europe, and North America.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSingapore, Singapore
HQ citystring
Singapore
HQ countrystring
Singapore
HQ regionstring
Asia
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
digital health intelligence, healthtech market intelligence, venture benchmarking platform, digital health analytics, health innovation research
Industry1 code
PRIMARYHLAGAJAC
Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
NAICS code2 codes
  • Software Publishers5132
  • Scientific Research and Development Services5417
SIC code1 code
  • Services-Computer Processing & Data Preparation7374
Product category
Digital Health Intelligence Platform
Social media profiles2 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1HealthTech Alpha SaaS Platform Subscriptions
TypeSubscription Recurring
Description

AI-native SaaS platform providing digital health intelligence with tiered access levels (Pro and Enterprise accounts). Delivers structured intelligence across ventures, markets, funding, partnerships, clinical evidence, and regulatory signals with governance-friendly outputs.

galengrowth.com
2Advisory Services
TypeProfessional Services
Description

Targeted expert support for high-stakes decisions, applying expert judgment on top of platform intelligence. Services include ecosystem strategy, market mapping, competitive benchmarking, portfolio evaluation, partner/M&A target identification, and transaction/investment due diligence.

galengrowth.com
3Research Reports & Briefings
TypeSubscription Recurring
Description

Reports and briefings powered by HealthTech Alpha data and analytics, covering digital health funding, AI in healthcare, clinical evidence, pharma innovation, health system transformation, and regional ecosystems. Premium reports available to HealthTech Alpha Pro and Enterprise accounts at no additional cost.

galengrowth.com
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Marketing or Sales, Operations
Pricing details2 tiers
1HealthTech Alpha Pro
ModelSubscriptionBilling cadenceAnnual
Notes

Entry-level platform access with digital health intelligence capabilities

galengrowth.com
2HealthTech Alpha Enterprise
ModelSubscriptionBilling cadenceAnnual
Notes

Full platform access including premium reports, deep analytics, and dedicated support

galengrowth.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 record
1HealthTech Alpha
Description

The company's flagship AI-driven SaaS platform for digital health intelligence, enabling clients to identify opportunities, benchmark markets, and make evidence-based decisions in Digital Health.

galengrowth.com
Core offering1 text field

Galen Growth operates HealthTech Alpha, an AI-native SaaS intelligence platform covering 12,000+ digital health ventures with 2+ billion proprietary data points, providing decision-grade intelligence on funding, partnerships, clinical evidence, and regulatory signals. The company layers Advisory services and Research reports on top of the platform, enabling enterprises to benchmark markets, assess ventures, and make evidence-based strategic, investment, and M&A decisions in digital health.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 150,000+ digital health leaders engaged through platform and research
+1 more record
Product overview1 text field

Galen Growth offers a unified platform-plus-services model anchored by HealthTech Alpha, an AI-native SaaS intelligence platform that aggregates and validates digital health venture data across funding, partnerships, clinical evidence, and regulatory signals. Around this core platform, Galen Growth delivers two complementary service layers: Advisory by Galen Growth provides expert strategic support for high-stakes decisions including ecosystem mapping, competitive benchmarking, and M&A due diligence; Research by Galen Growth delivers reports and briefings powered by HealthTech Alpha data. Additional offerings include HealthTech 250 (evidence-led venture rankings) and an Advisory Builder tool for structured inquiry submission. The portfolio serves life sciences companies, payers, institutional investors, and health systems across Asia-Pacific, Europe, and North America.

Product and service4 records
1HealthTech Alpha
CategoryDigital Health Intelligence Platform
Description

AI-native SaaS intelligence platform covering 12,000+ digital health ventures with 2+ billion proprietary data points, enabling enterprises to benchmark markets, assess ventures, identify partners, and make evidence-based decisions across funding, partnerships, clinical evidence, and regulatory signals.

2Advisory by Galen Growth
CategoryAdvisory and Consulting Services
Description

Expert advisory service powered by HealthTech Alpha, providing targeted strategic support for ecosystem strategy, market mapping, competitive benchmarking, portfolio evaluation, and M&A target identification for high-stakes decisions.

3Research by Galen Growth
CategoryResearch and Market Analysis
Description

Reports, briefings, and market analyses built on HealthTech Alpha data, offering insights on digital health funding, AI adoption, clinical evidence, pharma innovation, and ecosystem trends across global markets; available through the Digital Health Research Library of 114+ reports.

4HealthTech 250
CategoryDigital Health Intelligence
Description

Evidence-led ranking and analysis of the top 250 leading digital health ventures, providing intelligence on market leaders and investment targets.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-12-08
Description

All Health Tech appointed as exclusive sales partner for HealthTech Alpha in India. The partnership expands access for Indian pharmaceutical companies, insurers, corporates, investors, and government agencies to HealthTech Alpha—the world's most advanced digital health intelligence platform. All Health Tech leads all commercial activities in India, offering localised sales engagement, customer support, and onboarding to power stakeholder AI/LLM environments with digital health intelligence.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-01-01
Description

Partnership to expand HealthTech Alpha's ecosystem integrations and data sources, strengthening the platform's data coverage and analytical capabilities for digital health intelligence.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

AI-driven market intelligence platform covering venture capital, startups, and corporate strategy, with a dedicated healthcare/digital health practice. Closely comparable to Galen Growth's enterprise intelligence SaaS model and target buyer (corporate strategy, investors).

TypeBroad incumbent
Description

Global life sciences data, analytics, and technology services giant. Overlaps with Galen Growth in serving biopharma with healthcare market intelligence, though at vastly larger scale and broader scope.

TypeDirect peer
Description

Healthcare and digital health transaction intelligence platform. Comparable in offering deal, funding, and partnership data to investors and corporate development teams in healthcare.

TypeDirect peer
Description

Financial data and intelligence platform for venture, private equity, and M&A markets with healthcare coverage. Comparable data SaaS model, subscription tiering, and enterprise buyer overlap (institutional investors and corporate development teams).

TypeDirect peer
Description

Digital health insights, reports, and venture rankings; closely comparable thought leadership and digital health venture intelligence offering targeting investors and corporates.

TypeDirect peer
Description

Pharma commercial intelligence platform (parent of Citeline, Evaluate, Pharma Intelligence). Galen Growth's 2023 ecosystem partner; directly comparable in providing decision-grade pharma/digital health intelligence to biopharma.

TypeBroad incumbent
Description

Global management consultancy with a major healthcare practice. Overlaps with Galen Growth in digital health strategy and M&A advisory for pharma, payers, and providers, but competes from a consulting-services rather than SaaS perspective.

8Digital Health Intelligence (Informa)
TypeDirect peer
Description

Informa-owned digital health research, events, and intelligence service. Comparable in producing digital health reports, briefings, and ecosystem intelligence for healthcare buyers.

TypeDirect peer
Description

Healthcare commercial intelligence SaaS covering life sciences, providers, and healthcare IT. Comparable in targeting biopharma and MedTech enterprise buyers with subscription intelligence and analytics workflows.

TypeBroad incumbent
Description

Global strategy consulting with deep healthcare and digital health practice. Comparable in serving biopharma and MedTech on digital health strategy, market expansion, and due diligence, though delivered as advisory rather than a SaaS platform.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers14 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment7 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile6 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Galen Growth

Digital Health Intelligence Platformgalengrowth.com

Galen Growth operates HealthTech Alpha, an AI-native SaaS platform providing decision-grade intelligence on 12,000+ digital health ventures, serving enterprise clients in biopharma, MedTech, insurance, health systems, and institutional investing across APAC, Europe, and North America.

What Galen Growth does

Galen Growth is a privately held digital health intelligence company that builds and commercializes HealthTech Alpha, an AI-native SaaS platform aggregating and validating data on more than 12,000 digital health ventures and 2+ billion data points across funding, partnerships, clinical evidence, and regulatory signals. The platform applies a proprietary Digital Health Taxonomy, ontology framework, and Alpha Score™ metric to deliver point-in-time, governance-friendly intelligence used for benchmarking markets, evaluating ventures, and identifying partnership and M&A opportunities. Around the core platform, the company sells tiered Pro and Enterprise subscriptions, premium research reports and briefings (114+ in a public library), and a higher-margin Advisory service that applies expert judgment for ecosystem strategy, competitive benchmarking, portfolio evaluation, and due diligence.

The company serves enterprise clients across biopharma (GSK, Merck GHI), MedTech (Philips, Medtronic, GE Healthcare), insurance and reinsurance (Swiss Re, Prudential, Munich Re, Mercer Marsh Benefits, FWD, Bupa), health systems, and institutional investors (Munich Re Ventures, B Capital Group). GTM combines enterprise field sales with a product-led self-service model on the platform and channel partnerships for regional distribution — most recently an exclusive India arrangement with All Health Tech announced in December 2025. Pricing is quote-based and not publicly disclosed, reflecting a high-touch enterprise sales motion.

Galen Growth is incorporated in Singapore as Galen Growth Asia Pte. Ltd., with regional headquarters in Basel (Europe, opened 2020) and Boston (North America). The firm reports 1-10 employees, was founded in 2016, and has no disclosed institutional funding beyond a $50,000 seed round in November 2015, indicating a capital-efficient, founder-led operating model.

Galen Growth firmographics

Firmographics
Name
Galen Growth
Legal name
Galen Growth Asia Pte. Ltd.
Website
https://galengrowth.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
11–50 employees
Short description
Galen Growth operates HealthTech Alpha, an AI-native SaaS platform providing decision-grade intelligence on 12,000+ digital health ventures, serving enterprise clients in biopharma, MedTech, insurance, health systems, and institutional investing across APAC, Europe, and North America.
Ownership category
akta.pro rank

Galen Growth industry classification

Industry
Product category
Digital Health Intelligence Platform
NAICS
Software Publishers (5132), Scientific Research and Development Services (5417)
SIC
Services-Computer Processing & Data Preparation (7374)
akta.pro industry
PRIMARYHLAGAJAC
Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)

Keywords

  • Digital health intelligence
  • Healthtech market intelligence
  • Venture benchmarking platform
  • Digital health analytics
  • Health innovation research

Where Galen Growth is headquartered

Location

Headquarters

HQ city
Singapore
HQ country
Singapore
HQ region
Asia

Offices3 records

Markets served

Galen Growth business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

  1. HealthTech Alpha SaaS Platform Subscriptions: AI-native SaaS platform providing digital health intelligence with tiered access levels (Pro and Enterprise accounts). Delivers structured intelligence across ventures, markets, funding, partnerships, clinical evidence, and regulatory signals with governance-friendly outputs.
  2. Advisory Services: Targeted expert support for high-stakes decisions, applying expert judgment on top of platform intelligence. Services include ecosystem strategy, market mapping, competitive benchmarking, portfolio evaluation, partner/M&A target identification, and transaction/investment due diligence.
  3. Research Reports & Briefings: Reports and briefings powered by HealthTech Alpha data and analytics, covering digital health funding, AI in healthcare, clinical evidence, pharma innovation, health system transformation, and regional ecosystems. Premium reports available to HealthTech Alpha Pro and Enterprise accounts at no additional cost.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualHealthTech Alpha Pro
SubscriptionAnnualHealthTech Alpha Enterprise

Go-to-market motion3 records

Distribution channels4 records

Marketing channels9 records

Galen Growth product offering

Product offering

Core offering

Galen Growth operates HealthTech Alpha, an AI-native SaaS intelligence platform covering 12,000+ digital health ventures with 2+ billion proprietary data points, providing decision-grade intelligence on funding, partnerships, clinical evidence, and regulatory signals. The company layers Advisory services and Research reports on top of the platform, enabling enterprises to benchmark markets, assess ventures, and make evidence-based strategic, investment, and M&A decisions in digital health.

Product overview

Galen Growth offers a unified platform-plus-services model anchored by HealthTech Alpha, an AI-native SaaS intelligence platform that aggregates and validates digital health venture data across funding, partnerships, clinical evidence, and regulatory signals. Around this core platform, Galen Growth delivers two complementary service layers: Advisory by Galen Growth provides expert strategic support for high-stakes decisions including ecosystem mapping, competitive benchmarking, and M&A due diligence; Research by Galen Growth delivers reports and briefings powered by HealthTech Alpha data. Additional offerings include HealthTech 250 (evidence-led venture rankings) and an Advisory Builder tool for structured inquiry submission. The portfolio serves life sciences companies, payers, institutional investors, and health systems across Asia-Pacific, Europe, and North America.

Differentiator

Problem solved

Functional benefit

Brands

  • HealthTech Alpha: The company's flagship AI-driven SaaS platform for digital health intelligence, enabling clients to identify opportunities, benchmark markets, and make evidence-based decisions in Digital Health.

Products and services

  • HealthTech Alpha AI-native SaaS intelligence platform covering 12,000+ digital health ventures with 2+ billion proprietary data points, enabling enterprises to benchmark markets, assess ventures, identify partners, and make evidence-based decisions across funding, partnerships, clinical evidence, and regulatory signals.
  • Advisory by Galen Growth Expert advisory service powered by HealthTech Alpha, providing targeted strategic support for ecosystem strategy, market mapping, competitive benchmarking, portfolio evaluation, and M&A target identification for high-stakes decisions.
  • Research by Galen Growth Reports, briefings, and market analyses built on HealthTech Alpha data, offering insights on digital health funding, AI adoption, clinical evidence, pharma innovation, and ecosystem trends across global markets; available through the Digital Health Research Library of 114+ reports.
  • HealthTech 250 Evidence-led ranking and analysis of the top 250 leading digital health ventures, providing intelligence on market leaders and investment targets.

Quantifiable outcome

  • 150,000+ digital health leaders engaged through platform and research
  • +1 more outcomes

Companies that use Galen Growth

Customer profile

Named customers14 records

Segments7 records

Ideal customer profiles6 records

Galen Growth technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature4 records

Galen Growth partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • All Health TechcoreChannel Partner/ Reseller/ Distributor · 8 December 2025All Health Tech appointed as exclusive sales partner for HealthTech Alpha in India. The partnership expands access for Indian pharmaceutical companies, insurers, corporates, investors, and government agencies to HealthTech Alpha—the world's most advanced digital health intelligence platform. All Health Tech leads all commercial activities in India, offering localised sales engagement, customer support, and onboarding to power stakeholder AI/LLM environments with digital health intelligence.
  • NorstellacoreStrategic or Co-development Partner · 1 January 2023Partnership to expand HealthTech Alpha's ecosystem integrations and data sources, strengthening the platform's data coverage and analytical capabilities for digital health intelligence.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Galen Growth competitors and assessment

Company assessment

Direct peers

  • CB Insights: AI-driven market intelligence platform covering venture capital, startups, and corporate strategy, with a dedicated healthcare/digital health practice. Closely comparable to Galen Growth's enterprise intelligence SaaS model and target buyer (corporate strategy, investors).
  • DealForma: Healthcare and digital health transaction intelligence platform. Comparable in offering deal, funding, and partnership data to investors and corporate development teams in healthcare.
  • PitchBook: Financial data and intelligence platform for venture, private equity, and M&A markets with healthcare coverage. Comparable data SaaS model, subscription tiering, and enterprise buyer overlap (institutional investors and corporate development teams).
  • StartUp Health: Digital health insights, reports, and venture rankings; closely comparable thought leadership and digital health venture intelligence offering targeting investors and corporates.
  • Norstella: Pharma commercial intelligence platform (parent of Citeline, Evaluate, Pharma Intelligence). Galen Growth's 2023 ecosystem partner; directly comparable in providing decision-grade pharma/digital health intelligence to biopharma.
  • Digital Health Intelligence (Informa): Informa-owned digital health research, events, and intelligence service. Comparable in producing digital health reports, briefings, and ecosystem intelligence for healthcare buyers.
  • Definitive Healthcare: Healthcare commercial intelligence SaaS covering life sciences, providers, and healthcare IT. Comparable in targeting biopharma and MedTech enterprise buyers with subscription intelligence and analytics workflows.

Broad incumbents

  • IQVIA: Global life sciences data, analytics, and technology services giant. Overlaps with Galen Growth in serving biopharma with healthcare market intelligence, though at vastly larger scale and broader scope.
  • Bain & Company (Healthcare): Global management consultancy with a major healthcare practice. Overlaps with Galen Growth in digital health strategy and M&A advisory for pharma, payers, and providers, but competes from a consulting-services rather than SaaS perspective.
  • LEK Consulting Healthcare: Global strategy consulting with deep healthcare and digital health practice. Comparable in serving biopharma and MedTech on digital health strategy, market expansion, and due diligence, though delivered as advisory rather than a SaaS platform.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Galen Growth social profiles

Digital presence

Galen Growth financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Galen Growth leadership team

Management profile

Number of profiles

Profiles1 record

Galen Growth subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Galen Growth funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Galen Growth M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Galen Growth

What does Galen Growth do?

Galen Growth operates HealthTech Alpha, an AI-native SaaS intelligence platform covering 12,000+ digital health ventures with 2+ billion proprietary data points, providing decision-grade intelligence on funding, partnerships, clinical evidence, and regulatory signals. The company layers Advisory services and Research reports on top of the platform, enabling enterprises to benchmark markets, assess ventures, and make evidence-based strategic, investment, and M&A decisions in digital health.

Is Galen Growth a public or private company?

Galen Growth is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Galen Growth founded?

Galen Growth was founded in 2016. It employs 11 to 50 people.

Where is Galen Growth based?

Galen Growth is headquartered in Singapore, Singapore, in the Asia region.

How does Galen Growth make money?

Three revenue lines are on record. HealthTech Alpha SaaS Platform Subscriptions are the primary driver. The others are advisory Services and research Reports & Briefings.

Who are Galen Growth's main competitors?

Direct peers on record are CB Insights, DealForma, PitchBook, StartUp Health, Norstella, Digital Health Intelligence (Informa) and Definitive Healthcare. Broad incumbents are IQVIA, Bain & Company (Healthcare) and LEK Consulting Healthcare.

Does Galen Growth have an API?

No public API is recorded for Galen Growth.

What industry is Galen Growth in?

Galen Growth's product category is Digital Health Intelligence Platform. Its primary akta.pro industry code is HLAGAJAC, Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D). Its NAICS code is 5132 and its SIC code is 7374.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Galen Growth NewsBlogsThe article highlights Roche's $1.05 billion acquisition of PathAI, framing it as a significant event raising questions regarding AI infrastructure neutrality and vendor governance in the healthcare sector. The content primarily consists of aggregated headlines and summaries from Galen Growth’s HealthTech Alpha platform, covering broader digital health funding trends across regions like APAC, Europe, and the US for 2025 and 2026.Galen Growth NewsRe-Architecting Healthcare Delivery with AI: From labour-driven care to AI-powered systemsGalen Growth released its 2026 Digital Health report on Health Management Solutions, revealing that AI-powered ventures captured $4.4 billion (83%) of the $5.6 billion total venture funding deployed to this segment in 2025, representing 18.8% of all global digital health investment. The market is consolidating rapidly with average deal sizes tripling from $11.9 million in Q1 2022 to $35.4 million in Q1 2026, while M&A activity remains steady at 37–41 deals per year and partnership volume declined 25% as health systems shift toward selective enterprise-scale deployments. Regional strategies diverge significantly, with North America accounting for 41% of ventures and $4.5 billion in funding, Europe focusing on clinical intelligence, and Asia Pacific emerging as the fastest-growing market with 87% year-over-year funding growth.Galen Growth NewsWhat Is Digital Health? Definition, Taxonomy & OntologyThis article argues that "Digital Health" is an overused and inconsistently applied term that lacks the rigorous classification needed for serious market analysis, creating false comparability, fueling hype, and undermining due diligence and AI workflows. It proposes that Galen Growth's Digital Health Taxonomy and Ontology provide the structured framework needed to properly categorize, compare, and analyze digital health companies, technologies, and market segments. The piece contends that in the GenAI era, weak definitions become dangerous as AI systems amplify existing classification flaws, making disciplined taxonomy and ontology essential infrastructure for trusted intelligence and strategic decision-making.LinkedInAsia Pacific Digital Health 2025: Australia Leads, Women’s Health Surges, and a Cash Crunch LoomsGalen Growth's 2025 Asia Pacific digital health report shows regional funding grew 14% to $2.4 billion, outpacing North America's 7%, with Australia unexpectedly becoming the top-funded market at $548 million, surpassing China ($520M) and India ($416M). Women's Health emerged as the most funded therapeutic category with 179% year-on-year funding growth, while TechBio and Medical Diagnostics clusters attracted the highest capital as investors shifted toward deep-tech, infrastructure-heavy solutions. The report identifies a structural risk: growth-stage companies averaged 36.5 months since their last funding round—nearly 15 months longer than U.S. and Europe peers—raising concerns of down-rounds, forced consolidation, or shutdowns as the ecosystem matures.StatistaLeading countries for digital health funding Europe 2025The article discusses a report by Galen Growth that ranks the top countries in Europe for digital health funding in 2025, based on data compiled by Statista. It emphasizes the strategic importance of digital health investments across multiple European countries.ThesouthfirstGalen Growth appoints All Health Tech as exclusive sales partner for HealthTech Alpha in IndiaGalen Growth has appointed All Health Tech as the exclusive sales partner for its platform, HealthTech Alpha, in India, with the partnership announced on December 7, 2025. The collaboration aims to enhance support for corporate, investor, and policymaker engagement in India’s rapidly growing digital health market, allowing users access to extensive data on global health startups. This partnership positions All Health Tech as a key player in localizing the platform for Indian users and improving access to verified health innovation data.New Indian ExpressGalen Growth Appoints All Health Tech as Exclusive Sales Partner for HealthTech Alpha in IndiaGalen Growth, the global leader in digital health intelligence, announced a strategic partnership appointing All Health Tech as the exclusive Sales Partner for HealthTech Alpha in India. The partnership will expand access for Indian pharmaceutical companies, insurers, corporates, investors, and government agencies to HealthTech Alpha—the world's most advanced digital health intelligence platform containing over 2 billion data points on digital health startups globally. All Health Tech will lead all commercial activities in India, offering localised sales engagement, customer support, and onboarding to power stakeholder AI/LLM environments with digital health intelligence.